ENGNW enGene Therapeutics Inc.

Fundamentals / CIK 0001980845 / USD
Other share classes on CIK 0001980845: ENGN

enGene Therapeutics Inc. reported $288.3M in total assets and a net loss of $130.4M through October 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ENGNW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$0$0$0-$109.7MFY 2022 Net Income: -$24.46M2022FY 2023 Net Income: -$99.92M2023FY 2024 Net Income: -$55.14M2024FY 2025 Net Income: -$117.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Oct 31 Oct 31 Oct 31 Oct 31
Research & Development $94.48M $38.31M $16.46M $15.47M
Total Operating Expenses $123.2M $62.30M $26.06M $19.43M
Operating Income -$123.2M -$62.30M -$26.06M -$19.43M
EBITDA -$122.7M -$62.00M -$25.86M -$19.23M
Interest Income $9.43M $10.41M $1.12M $129K
Interest Expense $2.99M $2.80M $4.95M $1.42M
Income Before Tax -$117.3M -$55.16M -$99.90M -$24.44M
Income Tax Expense $0 -$19K $17K $22K
Net Income -$117.3M -$55.14M -$99.92M -$24.46M
Basic EPS $2.29 $1.46 $151.22 $44.30
Diluted EPS $2.29 $1.46 $151.22 $44.30
Basic Shares Outstanding 51.1M 37.8M 692.6K 655.2K
Diluted Shares Outstanding 51.1M 37.8M 692.6K 655.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Research & Development $20.09M $22.20M $22.25M $31.72M $22.57M $20.21M $19.97M $11.27M
Total Operating Expenses $34.01M $31.97M $31.18M $39.48M $29.95M $27.12M $26.61M $17.45M
Operating Income -$34.01M -$31.97M -$31.18M -$39.48M -$29.95M -$27.12M -$26.61M -$17.45M
EBITDA -$33.91M -$31.77M -$31.00M -$39.28M -$29.85M -$27.02M -$26.51M -$17.36M
Interest Income $2.40M $2.66M $2.74M $1.98M $2.23M $2.49M $2.73M $3.02M
Interest Expense $843K $745K $732K $750K $758K $734K $752K $756K
Income Before Tax -$32.50M -$30.23M -$29.75M -$38.38M -$28.75M -$25.57M -$24.60M -$15.28M
Income Tax Expense $0 $0 $0 -$497K $239K $240K $18K $19K
Net Income -$32.50M -$30.23M -$29.75M -$37.88M -$28.99M -$25.82M -$24.62M -$15.30M
Basic EPS -$0.47 -$0.43 $0.44 -- -$0.57 -$0.51 $0.48 --
Diluted EPS -$0.47 -$0.43 $0.44 -- -$0.57 -$0.51 $0.48 --
Basic Shares Outstanding 69.7M 69.7M 67.3M -- 51.1M 51.0M 51.0M --
Diluted Shares Outstanding 69.7M 69.7M 67.3M -- 51.1M 51.0M 51.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Oct 31 Oct 31 Oct 31 Oct 31
Cash & Cash Equivalents $50.15M $173.0M $81.52M $20.43M
Short-Term Investments $143.6M $65.33M -- --
Cash & Short-Term Investments $193.7M $238.3M $81.52M $20.43M
Total Current Assets $201.4M $247.4M $85.44M $22.58M
Property, Plant & Equipment, Net $2.48M $1.17M $589K $387K
Long-Term Investments $8.52M $59.53M -- --
Other Non-Current Assets $1.36M $1.37M $930K $939K
Total Non-Current Assets $20.08M $63.81M $1.52M $1.33M
Total Assets $221.5M $311.2M $86.96M $23.91M
Accounts Payable $6.69M $1.41M $1.16M $723K
Total Current Liabilities $31.98M $14.66M $5.26M $5.10M
Total Non-Current Liabilities $21.78M $23.90M $9.22M $42.30M
Total Liabilities $53.76M $38.56M $14.47M $47.41M
Total Debt (incl. Leases) $8.47M $1.80M -- --
Common Stock $513.3M $509.8M $259.4M $16.39M
Retained Earnings -$372.0M -$254.7M -$199.6M -$99.67M
Accumulated Other Comp. Income -$888K -$1.42M -$1.02M -$1.02M
Total Stockholders' Equity $167.7M $272.6M $72.49M -$76.61M
Total Equity $167.7M $272.6M $72.49M -$76.61M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Cash & Cash Equivalents $41.02M $29.83M $36.61M $50.15M $32.62M $57.55M $62.35M $173.0M
Short-Term Investments $225.3M $228.6M $239.3M $143.6M $169.3M $159.8M $151.5M $65.33M
Cash & Short-Term Investments $266.3M $258.5M $275.9M $193.7M $201.9M $217.4M $213.8M $238.3M
Total Current Assets $277.9M $270.0M $289.2M $201.4M $211.3M $228.0M $222.3M $247.4M
Property, Plant & Equipment, Net $2.16M $2.33M $2.44M $2.48M $1.88M $1.55M $1.37M $1.17M
Long-Term Investments $0 $26.71M $36.60M $8.52M $23.01M $34.11M $58.98M $59.53M
Other Non-Current Assets $1.39M $1.38M $1.39M $1.36M $1.38M $1.38M $1.58M $1.37M
Total Non-Current Assets $10.42M $37.52M $47.90M $20.08M $34.24M $38.68M $63.61M $63.81M
Total Assets $288.3M $307.5M $337.1M $221.5M $245.6M $266.7M $285.9M $311.2M
Accounts Payable $2.54M $1.79M $2.44M $6.69M $2.38M $1.57M $2.60M $1.41M
Total Current Liabilities $27.21M $21.48M $24.61M $31.98M $20.44M $18.00M $12.96M $14.66M
Total Non-Current Liabilities $30.82M $30.87M $30.96M $21.78M $24.44M $21.36M $23.03M $23.90M
Total Liabilities $58.03M $52.36M $55.57M $53.76M $44.88M $39.36M $35.98M $38.56M
Total Debt (incl. Leases) $7.92M $8.25M $8.54M $8.47M $8.26M $1.77M $1.75M $1.80M
Common Stock $632.0M $632.0M $632.0M $513.3M $510.2M $510.1M $509.8M $509.8M
Retained Earnings -$464.5M -$432.0M -$401.8M -$372.0M -$334.2M -$305.2M -$279.3M -$254.7M
Accumulated Other Comp. Income -$1.35M -$1.14M -$842K -$888K -$1.21M -$969K -$1.27M -$1.42M
Total Stockholders' Equity $230.3M $255.2M $281.5M $167.7M $200.7M $227.3M $249.9M $272.6M
Total Equity $230.3M $255.2M $281.5M $167.7M $200.7M $227.3M $249.9M $272.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Oct 31 Oct 31 Oct 31 Oct 31
Net Income -$117.3M -$55.14M -$99.92M -$24.46M
Depreciation & Amortization $500K $300K $200K $200K
Stock-Based Compensation $9.65M $5.32M $3.45M $116K
Change in Payables $4.94M $474K $373K -$197K
Operating Cash Flow -$99.24M -$48.28M -$24.74M -$17.59M
Capital Expenditure -$1.49M -$925K -$318K -$153K
Free Cash Flow -$100.7M -$49.21M -$25.06M -$17.75M
Purchases of Investments -$160.8M -$125.0M -- --
Investing Cash Flow -$25.14M -$126.0M -$318K -$153K
Common Stock Issued -- -- $56.89M --
Dividends Paid -- -- $0 --
Financing Cash Flow $1.52M $265.7M $86.15M $27.97M
Net Change in Cash -$122.9M $91.48M $61.09M $9.42M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Net Income -$32.50M -$30.23M -$29.75M -$37.88M -$28.99M -$25.82M -$24.62M -$15.30M
Depreciation & Amortization $100K $200K $189K $200K $100K $100K $102K $100K
Stock-Based Compensation $7.81M $4.14M $2.80M $2.61M $2.58M $2.65M $1.81M $1.66M
Change in Payables $744K -$625K -$4.27M $3.97M $818K -$974K $1.13M -$1.45M
Operating Cash Flow -$18.95M -$30.50M -$28.90M -$24.96M -$25.63M -$22.95M -$25.70M -$19.57M
Capital Expenditure $0 -$98K -$153K -$437K -$704K -$45K -$299K -$238K
Free Cash Flow -$18.95M -$30.60M -$29.06M -$25.40M -$26.34M -$22.99M -$26.00M -$19.81M
Purchases of Investments -$42.38M -$50.21M -$169.2M -$7.75M -$44.67M -$13.76M -$94.67M --
Investing Cash Flow $30.12M $23.64M -$126.3M $40.50M $1.38M $17.95M -$84.96M -$125.3M
Financing Cash Flow $23K $74K $141.7M $1.99M -$667K $199K $1.0K $60.16M
Net Change in Cash $11.20M -$6.79M -$13.54M $17.53M -$24.92M -$4.80M -$110.7M -$84.67M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Oct 31 Oct 31 Oct 31 Oct 31
Return on Equity (ROE) -69.9% -20.2% -137.8% --
Return on Assets (ROA) -53.0% -17.7% -114.9% -102.3%
Current Ratio 6.30x 16.87x 16.25x 4.42x
Quick Ratio 6.06x 16.26x 15.51x 4.00x
Debt to Equity 0.05x 0.01x -- --
EPS Growth (YoY) +56.8% -99.0% +241.4% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Return on Equity (ROE) -56.6% -49.7% -43.5% -69.9% -47.2% -35.1% -27.6% -20.2%
Return on Assets (ROA) -45.2% -41.2% -36.3% -53.0% -38.6% -30.0% -24.1% -17.7%
Current Ratio 10.21x 12.57x 11.75x 6.30x 10.34x 12.66x 17.16x 16.87x
Quick Ratio 9.79x 12.03x 11.21x 6.06x 9.88x 12.08x 16.50x 16.26x
Debt to Equity 0.03x 0.03x 0.03x 0.05x 0.04x 0.01x 0.01x 0.01x
EPS Growth (YoY) -- -- -8.3% -- -278.1% -234.2% +4.3% --
Source: SEC EDGAR CompanyFacts (CIK 0001980845) · from October 31, 2022 Data through July 31, 2026 · synced Nov 20, 2026, 05:48 UTC · Open in terminal